• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕罗西汀治疗中CYP 2D6代谢状态与性功能障碍的关系。

Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment.

作者信息

Zourková Alexandra, Hadasová Eva

机构信息

Department of Psychiatry, Masaryk University, Brno, 63900, Czech Republic.

出版信息

J Sex Marital Ther. 2002 Oct-Dec;28(5):451-61. doi: 10.1080/00926230290001565.

DOI:10.1080/00926230290001565
PMID:12378847
Abstract

This article describes the incidence of sexual dysfunction in 30 patients subjected to long-term treatment by paroxetine in dependence on the P 450 CYP 2D6 isoenzyme metabolic status. Measured on the Arizona Sexual Experience Scale (ASEX; McGahuey, Delgado, & Gelenberg, 1999), the incidence of sexual dysfunction in patients converted to CYP 2D6 poor metabolizers was markedly higher compared with patients who had no history of such conversion, a difference that reached the level of statistical significance. Our article discusses the incidence of sexual dysfunction in connection with reduced CYP 2D6 capacity.

摘要

本文描述了30例接受帕罗西汀长期治疗的患者性功能障碍的发生率,该发生率取决于细胞色素P450 2D6(CYP 2D6)同工酶的代谢状态。根据亚利桑那性体验量表(ASEX;McGahuey、Delgado和Gelenberg,1999)进行测量,转化为CYP 2D6慢代谢型的患者性功能障碍的发生率明显高于无此类转化史的患者,这一差异达到了统计学显著水平。我们的文章讨论了与CYP 2D6能力降低相关的性功能障碍的发生率。

相似文献

1
Relationship between CYP 2D6 metabolic status and sexual dysfunction in paroxetine treatment.帕罗西汀治疗中CYP 2D6代谢状态与性功能障碍的关系。
J Sex Marital Ther. 2002 Oct-Dec;28(5):451-61. doi: 10.1080/00926230290001565.
2
Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity.帕罗西汀所致性功能障碍、性别与细胞色素P450 2D6活性之间的联系。
J Sex Marital Ther. 2007 Jul-Sep;33(4):343-55. doi: 10.1080/00926230701385589.
3
Paroxetine-induced conversion of cytochrome P450 2D6 phenotype and occurence of adverse effects.帕罗西汀引起的细胞色素P450 2D6表型转换及不良反应的发生
Gen Physiol Biophys. 2003 Mar;22(1):103-13.
4
Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.吗氯贝胺、帕罗西汀、舍曲林和文拉法辛治疗期间抗抑郁药引起的性功能障碍。
J Clin Psychiatry. 2000 Apr;61(4):276-81. doi: 10.4088/jcp.v61n0406.
5
The serotonin syndrome scale: first results on validity.
Eur Arch Psychiatry Clin Neurosci. 1998;248(2):96-103. doi: 10.1007/s004060050024.
6
Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.在度洛西汀治疗重度抑郁症的4项双盲、安慰剂对照和帕罗西汀对照试验中评估性功能。
J Clin Psychiatry. 2005 Jun;66(6):686-92. doi: 10.4088/jcp.v66n0603.
7
A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder.在伴有抑郁障碍的情况下,从氟伏沙明交叉滴定转换为帕罗西汀时出现不良反应的病例,同时伴有血浆氟伏沙明水平升高。
World J Biol Psychiatry. 2009;10(4 Pt 2):620-2. doi: 10.1080/15622970802118349.
8
Cytochrome P450 2D6 genotype does not predict SSRI (fluoxetine or paroxetine) induced hyponatraemia.细胞色素P450 2D6基因型不能预测选择性5-羟色胺再摄取抑制剂(氟西汀或帕罗西汀)诱发的低钠血症。
Hum Psychopharmacol. 2002 Jun;17(4):187-90. doi: 10.1002/hup.394.
9
Female sexual stimulation during antidepressant treatment.抗抑郁治疗期间的女性性刺激
Pharmacotherapy. 1997 May-Jun;17(3):612-6.
10
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.与选择性5-羟色胺再摄取抑制剂相关的女性性功能副作用:33例患者的描述性临床研究
Int J Psychiatry Med. 1995;25(3):239-48. doi: 10.2190/N6C0-DWX2-G4EA-7688.

引用本文的文献

1
Delayed Ejaculation: Pathophysiology, Diagnosis, and Treatment.延迟射精:病理生理学、诊断与治疗
World J Mens Health. 2018 Jan;36(1):22-40. doi: 10.5534/wjmh.17051.
2
Sprague-Dawley and Fischer female rats differ in acute effects of fluoxetine on sexual behavior.Sprague-Dawley 和 Fischer 雌性大鼠在氟西汀对性行为的急性影响方面存在差异。
J Sex Med. 2013 Feb;10(2):350-61. doi: 10.1111/j.1743-6109.2012.02981.x. Epub 2012 Oct 30.
3
Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.人细胞色素 P450 2D6 的多态性及其临床意义:第二部分。
Clin Pharmacokinet. 2009;48(12):761-804. doi: 10.2165/11318070-000000000-00000.
4
Genetics and psychopharmacology: prospects for individualized treatment.遗传学与精神药理学:个性化治疗的前景
Essent Psychopharmacol. 2005;6(4):193-208.